Search

Your search keyword '"Ferrer, Sandra Fert"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Ferrer, Sandra Fert" Remove constraint Author: "Ferrer, Sandra Fert"
36 results on '"Ferrer, Sandra Fert"'

Search Results

1. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.

2. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

3. The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

4. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

5. The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

6. Additional file 8 of Exploring the link between MORF4L1 and risk of breast cancer

7. Additional file 7 of Exploring the link between MORF4L1 and risk of breast cancer

8. Additional file 16 of Exploring the link between MORF4L1 and risk of breast cancer

9. Additional file 5 of Exploring the link between MORF4L1 and risk of breast cancer

10. Additional file 9 of Exploring the link between MORF4L1 and risk of breast cancer

11. Additional file of Exploring the link between MORF4L1 and risk of breast cancer

12. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

13. Exploring the link between MORF4L1 and risk of breast cancer

14. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

15. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

16. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

17. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

18. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

19. Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers

20. Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers

21. Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk

22. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

23. A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers

24. Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

25. Common Variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 Are Associated with Breast Cancer Risk for BRCA1 and/or BRCA2 Mutation Carriers

26. The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

27. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

28. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

29. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

30. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

31. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

32. Exploring the link between MORF4L1 and risk of breast cancer

33. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

34. Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.

35. Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.

36. A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers.

Catalog

Books, media, physical & digital resources